APPLICATION
ANDA217634
TYPE
ANDA
ORIGINAL APPROVAL
2023-12-21
LATEST ACTION
2024-09-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 40MG BASE · TABLET · ORAL
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 10MG BASE · TABLET · ORAL
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 80MG BASE · TABLET · ORAL
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 20MG BASE · TABLET · ORAL
Approval history
2024-09-30Labeling · Supplement 1 · standardAP
2023-12-21UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.